Quantification of the Mutant CALR Allelic Burden by Digital PCR: Application to Minimal Residual Disease Evaluation after Bone Marrow Transplantation.

[1]  J. Chi,et al.  Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring , 2015, Annals of Hematology.

[2]  E. Solary,et al.  Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution , 2014, Leukemia.

[3]  S. Langabeer,et al.  Assessment of CALR mutations in myelofibrosis patients, post‐allogeneic stem cell transplantation , 2014, British journal of haematology.

[4]  J. Kiladjian,et al.  Interferon alfa therapy in CALR-mutated essential thrombocythemia. , 2014, The New England journal of medicine.

[5]  A. Tordai,et al.  Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations , 2014, Haematologica.

[6]  Min Yu,et al.  Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR. , 2014, The Journal of molecular diagnostics : JMD.

[7]  J. D. Fitzpatrick,et al.  Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. , 2013, The New England journal of medicine.

[8]  G. Superti-Furga,et al.  Somatic mutations of calreticulin in myeloproliferative neoplasms. , 2013, The New England journal of medicine.

[9]  Christopher M. Hindson,et al.  Absolute quantification by droplet digital PCR versus analog real-time PCR , 2013, Nature Methods.

[10]  T. Barbui,et al.  Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study , 2013, Leukemia.

[11]  D. Niederwieser,et al.  JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse , 2013, Haematologica.

[12]  Benjamin J. Hindson,et al.  Evaluation of a Droplet Digital Polymerase Chain Reaction Format for DNA Copy Number Quantification , 2011, Analytical chemistry.

[13]  T. Barbui,et al.  Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele. , 2009, Blood.

[14]  Y. Hildebrandt,et al.  JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation. , 2009, Blood.

[15]  S. Ellard,et al.  Concordance of assays designed for the quantification of JAK2V617F: a multicenter study , 2009, Haematologica.

[16]  S. Chevret,et al.  Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera. , 2008, Blood.

[17]  R. Mesa,et al.  Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival , 2008, Leukemia.

[18]  Paola Guglielmelli,et al.  Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. , 2007, Blood.

[19]  N. Kröger,et al.  Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis. , 2007, Blood.

[20]  M. Stratton,et al.  JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. , 2007, The New England journal of medicine.

[21]  P. Campbell,et al.  Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. , 2006, Blood.

[22]  François Girodon,et al.  The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera. , 2006, Blood.

[23]  Sandra A. Moore,et al.  MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia , 2006, PLoS medicine.

[24]  Stefan N Constantinescu,et al.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. , 2005, Nature.

[25]  K. Kinzler,et al.  Digital PCR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Helen E White,et al.  Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms. , 2015, Leukemia research.